Ginkgo Bioworks Holdings (DNA) Gross Margin (2020 - 2026)
Ginkgo Bioworks Holdings posted quarterly Gross Margin of 84.09% for Q1 2026, down 521.0% year-on-year from 19.97% in Q1 2025, and down 52.38% on a QoQ basis from 176.58% in Q4 2025.
Ginkgo Bioworks Holdings (DNA) has 7 years of Gross Margin data on file, last reported at 84.09% in Q1 2026.
- For the quarter ending Q1 2026, Gross Margin fell 521.0% year-over-year to 84.09%; the trailing twelve-month figure through Mar 2026 stood at 106.31% (down 29.0% YoY), and the FY2025 full-year result was 100.0%, changed 0.0% from the prior year.
- Gross Margin for Q1 2026 stood at 84.09%, down from 176.58% in the prior quarter.
- Across five years, Gross Margin topped out at 236.37% in Q4 2023 and bottomed at 113.83% in Q2 2023.
- The 5-year median for Gross Margin is 88.78% (2024), against an average of 67.96%.
- Peak annual rise in Gross Margin reached 23581 bps in 2023, while the deepest fall reached 9122 bps in 2023.
- A 5-year view of Gross Margin shows it stood at 0.56% in 2022, then jumped by 42139 bps to 236.37% in 2023, then fell by 28 bps to 170.69% in 2024, then advanced by 3 bps to 176.58% in 2025, then sank by 52 bps to 84.09% in 2026.
- The last three Gross Margin figures came in at 84.09% (Q1 2026), 176.58% (Q4 2025), and 78.95% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 79.04% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 86.85% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 91.79% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 82.22% |
| 10 | Ginkgo Bioworks Holdings | 542.03 Mn | 542.03 Mn | 16.38 Mn | 84.09% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 84.09% |
| Dec 31, 2025 | 176.58% |
| Sep 30, 2025 | 78.95% |
| Jun 30, 2025 | 89.15% |
| Mar 31, 2025 | 89.30% |
| Dec 31, 2024 | 170.69% |
| Sep 30, 2024 | 88.78% |
| Jun 30, 2024 | 96.59% |
| Mar 31, 2024 | 100.00% |
| Dec 31, 2023 | 236.37% |
| Sep 30, 2023 | 100.00% |
| Jun 30, 2023 | -113.83% |
| Mar 31, 2023 | 12.03% |
| Dec 31, 2022 | 0.56% |
| Sep 30, 2022 | 0.55% |
| Jun 30, 2022 | -22.61% |
| Mar 31, 2022 | -31.84% |
| Dec 31, 2021 | -9.15% |
| Sep 30, 2021 | -32.45% |
| Jun 30, 2021 | -10.37% |
| Mar 31, 2021 | -68.13% |
| Dec 31, 2020 | 72.22% |
| Sep 30, 2020 | 100.00% |